Post hoc analysis of a randomized, double-blind, prospective trial evaluating a CXCR1/2 inhibitor in new-onset type 1 diabetes: endo-metabolic features at baseline identify a subgroup of responders
出版年份 2023 全文链接
标题
Post hoc analysis of a randomized, double-blind, prospective trial evaluating a CXCR1/2 inhibitor in new-onset type 1 diabetes: endo-metabolic features at baseline identify a subgroup of responders
作者
关键词
-
出版物
Frontiers in Endocrinology
Volume 14, Issue -, Pages -
出版商
Frontiers Media SA
发表日期
2023-06-20
DOI
10.3389/fendo.2023.1175640
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Ladarixin, an inhibitor of IL ‐8 receptors CXCR1 and CXCR2 , in new‐onset type 1 diabetes: a multicenter, randomized, double‐blind, placebo‐controlled trial
- (2022) Lorenzo Piemonti et al. DIABETES OBESITY & METABOLISM
- Neutrophils in autoimmunity: when the hero becomes the villain
- (2022) Samal Bissenova et al. CLINICAL AND EXPERIMENTAL IMMUNOLOGY
- Cellular heterogeneity in disease severity and clinical outcome: Granular understanding of immune response is key
- (2022) Kriti Khare et al. Frontiers in Immunology
- Two-Year Follow-up From the T1GER Study: Continued Off-Therapy Metabolic Improvements in Children and Young Adults With New-Onset T1D Treated With Golimumab and Characterization of Responders
- (2022) Mark R. Rigby et al. DIABETES CARE
- Low-dose ATG/GCSF in Established Type 1 Diabetes: A Five-Year Follow-up Report
- (2021) Andrea Lin et al. DIABETES
- Innate Immunity Mediated Inflammation and Beta Cell Function: Neighbors or Enemies?
- (2021) Antonio Citro et al. Frontiers in Endocrinology
- Immunotherapy: Building a bridge to a cure for type 1 diabetes
- (2021) Jeffrey A. Bluestone et al. SCIENCE
- IL-6 receptor blockade does not slow β cell loss in new-onset type 1 diabetes
- (2021) Carla J. Greenbaum et al. JCI Insight
- Safety and feasibility of intradermal injection with tolerogenic dendritic cells pulsed with proinsulin peptide—for type 1 diabetes
- (2020) Tatjana Nikolic et al. Lancet Diabetes & Endocrinology
- Golimumab and Beta-Cell Function in Youth with New-Onset Type 1 Diabetes
- (2020) Teresa Quattrin et al. NEW ENGLAND JOURNAL OF MEDICINE
- Cell Autonomous Dysfunction and Insulin Resistance in Pancreatic α Cells
- (2019) Norikiyo Honzawa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- An Anti-CD3 Antibody, Teplizumab, in Relatives at Risk for Type 1 Diabetes
- (2019) Kevan C. Herold et al. NEW ENGLAND JOURNAL OF MEDICINE
- VEGF levels in plasma in relation to metabolic control, inflammation, and microvascular complications in type-2 diabetes
- (2018) Qin Zhang et al. MEDICINE
- Treatment of type 1 diabetes with teplizumab: clinical and immunological follow-up after 7 years from diagnosis
- (2018) Ana Luisa Perdigoto et al. DIABETOLOGIA
- The Expanding Role of Natural Killer Cells in Type 1 Diabetes and Immunotherapy
- (2016) Chris Fraker et al. Current Diabetes Reports
- Antithymocyte Globulin Plus G-CSF Combination Therapy Leads to Sustained Immunomodulatory and Metabolic Effects in a Subset of Responders With Established Type 1 Diabetes
- (2016) Michael J. Haller et al. DIABETES
- Enhanced T cell responses to IL-6 in type 1 diabetes are associated with early clinical disease and increased IL-6 receptor expression
- (2016) Christian Hundhausen et al. Science Translational Medicine
- Neutrophils in type 1 diabetes
- (2016) Juan Huang et al. Journal of Diabetes Investigation
- Association between serum adiponectin and HbA1c is independent of the severity of clinical presentation in young adults with new onset type 1 diabetes
- (2016) S. Pilacinski et al. JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION
- Recommendations for the Definition of Clinical Responder in Insulin Preservation Studies
- (2014) C. A. Beam et al. DIABETES
- CXCR1/2 Inhibition Blocks and Reverses Type 1 Diabetes in Mice
- (2014) Antonio Citro et al. DIABETES
- Gene expression analysis of human islets in a subject at onset of type 1 diabetes
- (2013) Johan Hopfgarten et al. ACTA DIABETOLOGICA
- Reduction of Circulating Neutrophils Precedes and Accompanies Type 1 Diabetes
- (2013) A. Valle et al. DIABETES
- Teplizumab (Anti-CD3 mAb) Treatment Preserves C-Peptide Responses in Patients With New-Onset Type 1 Diabetes in a Randomized Controlled Trial: Metabolic and Immunologic Features at Baseline Identify a Subgroup of Responders
- (2013) K. C. Herold et al. DIABETES
- VEGF Levels in Plasma in Relation to Platelet Activation, Glycemic Control, and Microvascular Complications in Type 1 Diabetes
- (2013) R. O. Schlingemann et al. DIABETES CARE
- Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials
- (2013) Antoinette Moran et al. LANCET
- Serum adipokines as biomarkers of beta-cell function in patients with type 1 diabetes: positive association with leptin and resistin and negative association with adiponectin
- (2012) Minh Nguyet Pham et al. DIABETES-METABOLISM RESEARCH AND REVIEWS
- Teplizumab treatment may improve C-peptide responses in participants with type 1 diabetes after the new-onset period: a randomised controlled trial
- (2012) K. C. Herold et al. DIABETOLOGIA
- Crosstalk between neutrophils, B-1a cells and plasmacytoid dendritic cells initiates autoimmune diabetes
- (2012) Julien Diana et al. NATURE MEDICINE
- Receptor binding mode and pharmacological characterization of a potent and selective dual CXCR1/CXCR2 non-competitive allosteric inhibitor
- (2011) R Bertini et al. BRITISH JOURNAL OF PHARMACOLOGY
- Increased T Cell Proliferative Responses to Islet Antigens Identify Clinical Responders to Anti-CD20 Monoclonal Antibody (Rituximab) Therapy in Type 1 Diabetes
- (2011) K. C. Herold et al. JOURNAL OF IMMUNOLOGY
- Etanercept Treatment in Children With New-Onset Type 1 Diabetes: Pilot randomized, placebo-controlled, double-blind study
- (2009) L. Mastrandrea et al. DIABETES CARE
- Rituximab, B-Lymphocyte Depletion, and Preservation of Beta-Cell Function
- (2009) Mark D. Pescovitz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Serum Monocyte Chemoattractant Protein-1 Concentrations Associate With Diabetes Status but Not Arterial Stiffness in Children With Type 1 Diabetes
- (2008) I. Zineh et al. DIABETES CARE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExplorePublish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn More